Added to YB: 2025-03-07
Pitch date: 2025-01-18
SDGR [bullish]
Schrödinger, Inc.
-40.19%
current return
Author Info
No bio for this author
Company Info
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally.
Market Cap
$907.3M
Pitch Price
$19.26
Price Target
57.00 (+395%)
Dividend
N/A
EV/EBITDA
-4.35
P/E
-8.72
EV/Sales
2.43
Sector
Health Care Technology
Category
value
Schrödinger, Inc. - $SDGR
SDGR: Undervalued biotech/software hybrid. Software biz worth $13/share. Free option on drug discovery partnerships & pipeline. 200%+ upside vs 25% downside. Catalysts: 2025 clinical data, new partnerships, software growth. Comps like Nimbus/Morphic show potential. Market mispricing due to complexity.
Read full article (16 min)